Anavex Life Sciences Corp. (AVXL)
AVXL moved a median of -0.10% 30 minutes after news, and -0.29% by the close. How AVXL actually reacts to news — the realized, point-in-time move the market made, measured across 839 labeled events over the last three years with zero look-ahead.
AVXL’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 46% | 836 |
| 30-min | -0.10% | 46% | 836 |
| 60-min | -0.13% | 46% | 836 |
| to close | -0.29% | 43% | 835 |
| Middle 50% of AVXL reactions | -0.98% to +1.05% |
|---|---|
| Median reaction (30-min) | -0.10% |
| Measured reactions | 839 |
Half of all Anavex Life Sciences Corp. news events land between -0.98% and +1.05% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when AVXL moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to AVXL's baseline. Nothing else.
Recent AVXL events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome | Press release | GlobeNewswire | -7.48% | — | |
| Form 8-K ANAVEX LIFE SCIENCES For: Oct 15 | SEC filing · Form 8-K | SEC EDGAR | -7.48% | — | |
| Kaplan Fox Encourages Anavex Life Sciences Corp. (NASDAQ: AVXL) Investors to Contact the Firm Before the Deadline on November 30, 2026 | Press release | ACCESS Newswire | -7.48% | — | |
| Anavex Life Sciences Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AVXL | Press release | PR Newswire | +0.41% | +2.72% | |
| Anavex Life Sciences Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AVXL | Press release | PR Newswire | +0.34% | -8.10% | |
| Important Notice to Long-Term Shareholders of Anavex Life Sciences Corp. (NASDAQ: AVXL); Ardelyx, Inc. (NASDAQ: ARDX); Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI): Grabar Law Office is Investigating Cla | Press release | GlobeNewswire | +0.34% | -8.10% | |
| Anavex Life Sciences Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – AVXL | Press release | Business Wire | +0.45% | -0.49% | |
| Form 8-K ANAVEX LIFE SCIENCES For: Sep 24 | SEC filing · Form 8-K | SEC EDGAR | +0.43% | +0.43% | |
| Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting | Press release | GlobeNewswire | -1.30% | +1.74% | |
| PVG Asset Management Announces Plan for First 100 Days at Anavex Life Sciences | Press release | GlobeNewswire | +0.82% | -0.41% | |
| Glass Lewis Recommends Anavex Stockholders Vote the GOLD Universal Proxy Card, Citing “Functionally Inert Stewardship” in Support of PVG Asset Management’s Call for Change | Press release | GlobeNewswire | +0.21% | +0.00% | |
| Form DEFA14A ANAVEX LIFE SCIENCES | SEC filing · Form DEFA14A | SEC EDGAR | +0.82% | -3.28% | |
| Form DEFA14A ANAVEX LIFE SCIENCES | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -0.38% | |
| Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote “FOR” All Six of Anavex’s Highly Qualified Director Nominees | Press release | GlobeNewswire | +0.00% | -0.38% | |
| PVG Asset Management Believes ISS Acknowledges Anavex’s Repeated Missteps, Failed Board Oversight, Lack of Director Stock Ownership, and AVXL Stock Price Underperformance | Press release | GlobeNewswire | -1.16% | -5.79% | |
| PVG Asset Management to Host Investor Call Regarding Anavex Life Sciences Proxy Campaign | Press release | GlobeNewswire | -0.19% | +0.57% | |
| Form 8-K ANAVEX LIFE SCIENCES For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | -0.18% | -1.84% | |
| PVG Asset Management Issues Important Information About Anavex Life Sciences (AVXL) | Press release | GlobeNewswire | -0.70% | -4.18% | |
| Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET | Press release | GlobeNewswire | -0.89% | +1.42% | |
| Form DEFA14A ANAVEX LIFE SCIENCES | SEC filing · Form DEFA14A | SEC EDGAR | +1.23% | -3.17% | |
| Form DEFA14A ANAVEX LIFE SCIENCES | SEC filing · Form DEFA14A | SEC EDGAR | -0.89% | +1.42% | |
| PVG Sends Open Letter to Anavex Stockholders Detailing the Need for Change at the Company | Press release | GlobeNewswire | +0.00% | +1.42% | |
| Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement | Press release | GlobeNewswire | -0.34% | -1.72% | |
| Form 8-K ANAVEX LIFE SCIENCES For: Sep 02 | SEC filing · Form 8-K | SEC EDGAR | -0.34% | -1.72% | |
| Form DEFA14A ANAVEX LIFE SCIENCES | SEC filing · Form DEFA14A | SEC EDGAR | +2.43% | +0.35% | |
| PVG Asset Management Corporation Files Definitive Proxy Statement and Launches Shareholder Website in Connection with Anavex Life Sciences Corp.’s 2026 Annual Meeting | Press release | GlobeNewswire | +2.43% | +0.35% | |
| Form DEFA14A ANAVEX LIFE SCIENCES | SEC filing · Form DEFA14A | SEC EDGAR | +0.17% | -5.08% | |
| Form 10-K/A ANAVEX LIFE SCIENCES For: Sep 30 | SEC filing · Form 10-K | SEC EDGAR | +0.17% | -5.08% | |
| Form 10-Q ANAVEX LIFE SCIENCES For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.17% | -5.08% | |
| Form 10-Q ANAVEX LIFE SCIENCES For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.17% | -5.08% | |
| Form 10-Q/A ANAVEX LIFE SCIENCES For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.17% | -5.08% | |
| Anavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update | Press release | GlobeNewswire | +4.99% | +5.64% | |
| Form 8-K ANAVEX LIFE SCIENCES For: Aug 25 | SEC filing · Form 8-K | SEC EDGAR | +4.99% | +5.64% | |
| Form DEFA14A ANAVEX LIFE SCIENCES | SEC filing · Form DEFA14A | SEC EDGAR | -2.79% | -3.42% | |
| Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees | Press release | GlobeNewswire | -0.34% | +0.00% | |
| Form 8-K ANAVEX LIFE SCIENCES For: Aug 17 | SEC filing · Form 8-K | SEC EDGAR | -0.34% | +0.00% | |
| Form DEFA14A ANAVEX LIFE SCIENCES | SEC filing · Form DEFA14A | SEC EDGAR | -0.34% | +0.00% | |
| Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders | Press release | GlobeNewswire | +0.30% | +4.15% | |
| Form 8-K ANAVEX LIFE SCIENCES For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | +1.14% | -2.57% | |
| Form DEFA14A ANAVEX LIFE SCIENCES | SEC filing · Form DEFA14A | SEC EDGAR | +1.14% | -2.57% | |
| Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation | Press release | GlobeNewswire | +0.36% | +6.88% | |
| Form 8-K ANAVEX LIFE SCIENCES For: Aug 03 | SEC filing · Form 8-K | SEC EDGAR | +0.36% | +6.88% | |
| Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update | Press release | GlobeNewswire | +2.79% | +7.57% | |
| Form 8-K ANAVEX LIFE SCIENCES For: Jul 30 | SEC filing · Form 8-K | SEC EDGAR | +2.79% | +7.57% | |
| Form 8-K ANAVEX LIFE SCIENCES For: Jul 20 | SEC filing · Form 8-K | SEC EDGAR | +0.41% | +0.41% | |
| Form 8-K ANAVEX LIFE SCIENCES For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | +1.29% | +6.50% | |
| Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification | Press release | GlobeNewswire | +0.74% | -0.18% | |
| Form 8-K ANAVEX LIFE SCIENCES For: May 20 | SEC filing · Form 8-K | SEC EDGAR | +0.74% | -0.18% | |
| Form 8-K ANAVEX LIFE SCIENCES For: May 11 | SEC filing · Form 8-K | SEC EDGAR | +0.51% | -1.37% | |
| Form NT 10-Q ANAVEX LIFE SCIENCES For: Mar 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | -5.56% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the AVXL section they belong to.
Where else AVXL is measured.
AVXL earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NEWLINK GENETICS (NLNK) | 843 | 0.00% | 49% |
| Integra LifeSciences Holdings Corporation (IART) | 841 | -0.13% | 43% |
| Assertio Holdings, Inc. (ASRT) | 833 | -0.02% | 46% |
| Masimo Corporation (MASI) | 833 | -0.02% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Anavex Life Sciences Corp.'s median reaction calculated?
Every labeled AVXL news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 839 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 46% of AVXL's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does AVXL's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.